In vitro model showed PD-L1/PD-L2 expressing monocytes/TAMs suppressed activation of PD-1hi NK cells in Hodgkin lymphoma20 and in vivo study also found the PD-L1(+) monocytes effectively suppressed tumor-specific T cell immunity21. The gene discussed is PDCD1LG2; the disease is neoplasm.